Is chemodenervation with incobotulinumtoxinA an alternative to invasive chronic anal fissure treatments?

Authors

Institutions

Publication Details

Journal
BMC Gastroenterology
Published
2024-09-30
DOI
https://doi.org/10.1186/s12876-024-03428-z
Primary Topic
Anorectal Disease Treatments and Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Is chemodenervation with incobotulinumtoxinA an alternative to invasive chronic anal fissure treatments?

Peter De Cruz, Carlos D. Bustamante, L. Herranz Arriero, J. C. Santiago et al.
BMC Gastroenterology
Anorectal Disease Treatments and Outcomes
article

Is chemodenervation with incobotulinumtoxinA an alternative to invasive chronic anal fissure treatments?

Peter De Cruz, Carlos D. Bustamante, L. Herranz Arriero, J. C. Santiago, T Balsa, L. Béjar, J Asanza, Rosario Garrido, Torres Calderón
article en

Abstract

No abstract available for this paper.
BMC GastroenterologyVol. 24(1)
Hospital General Nuestra Señora del Prado (ES), Hospital Universitario de Guadalajara (ES)
Merz Pharmaceuticals
Good health and well-being
Openalex Percentile: Top 69%
Anorectal Disease Treatments and Outcomes
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.